CID1172084 is a novel high-potent GPR55 agonist that interacts with cannabinoid receptors.
Uses
CID1172084 (compound 3) is a selective GPR55 agonist (EC50=0.16 μM). CID1172084 is more than 100-fold selective for GPR55 over GPR35, CB1, and CB2. CID1172084 can be used to further explore the biological functions and signaling pathways of the GPR55 receptor[1].
References
[1] Kotsikorou, et al. "Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands." Biochemistry 50.25 (2011): 5633-5647 DOI:10.1021/bi200010k
